Hologic to Acquire Diagenode for ~$159M
Shots:
- Hologic to acquire Diagenode for ~$159M. The transaction will expand and diversifies Hologic’s diagnostic business across test menu- customer segments and geography
- The acquisition will strengthen Hologic’s molecular diagnostics business by expanding international its capabilities and allow it to offer a broader more differentiated test menu
- Diagenode and Hologic previously collaborated to develop Hologic’s Panther Fusion assays for detecting streptococcus and Bordetella
Ref: Businesswire | Image: Hologic
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com